The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > ARCHIVE
ARCHIVE
- GE Marquette Medical Systems Japan: Dash 4000 System
June 18, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIE -2-
June 18, 2001
- Nicolet Biomedical, GE Marquette Medical Systems Japan Reinforce Alliance
June 18, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -3-
June 18, 2001
- OTC NEWS IN BRIEF
June 18, 2001
- Tsumura to Jointly Study Cultivation of Crude Drugs with Chinese Firm
June 18, 2001
- Pharmacists Regarded as 4th Most Reliable: Survey
June 18, 2001
- Discussions Must Be Restarted from 10% R-zone: Mr Matsutani
June 18, 2001
- Kahma: Net Loss of \670 Million
June 18, 2001
- CS Yakuhin to Reduce Ratio of Expenses to Gross Revenue to 8%
June 18, 2001
- NIC Corp: Sales of Drug Dispensing Business Up 28.8%
June 18, 2001
- BUSINESS NEWS IN BRIEF
June 18, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -7-
June 11, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 11, 2001
- Sysmex: Sales Down in US, Japan, but Up in Europe, Asia
June 11, 2001
- 2% Price Adjustment Range Needs Urgent Review: FJPWA
June 11, 2001
- Olympus: Good Sales of Medical Endoscopes Overseas Drive Sales, Profits
June 11, 2001
- Nippon BD Ties Up with TAUNS Regarding Infectious Disease Diagnosis Kits
June 11, 2001
- Richfield to Embark on MR Dispatching Business
June 11, 2001
- Olympus: New Endoscope Position Detective Unit
June 11, 2001
ページ
Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…